Soleno Therapeutics, Inc. (FRA:6XC)
33.14
-0.90 (-2.64%)
At close: Jan 30, 2026
Soleno Therapeutics Employees
Soleno Therapeutics had 152 employees as of September 30, 2025. The number of employees increased by 60 or 65.22% compared to the same quarter last year.
Employees
152
Change
60
Growth
65.22%
Revenue / Employee
€553,294
Profits / Employee
€439,888
Market Cap
1.74B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 152 | 60 | 65.22% |
| Jun 30, 2025 | 133 | - | - |
| Mar 31, 2025 | 115 | 82 | 248.48% |
| Dec 31, 2024 | 92 | 59 | 178.79% |
| Dec 31, 2023 | 33 | 8 | 32.00% |
| Dec 31, 2022 | 25 | 5 | 25.00% |
| Dec 31, 2021 | 20 | 3 | 17.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Paul Hartmann AG | 10,082 |
| Mainova AG | 3,416 |
| Gelsenwasser AG | 1,898 |
| Maschinenfabrik Berthold Hermle AG | 1,607 |
| EUROKAI GmbH & Co. KGaA | 950 |
| tonies SE | 567 |
| Lechwerke AG | 459 |
| Northern Data AG | 199 |
Soleno Therapeutics News
- 15 days ago - SLNO INVESTOR ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Fraud Investigation - GlobeNewsWire
- 17 days ago - Soleno Therapeutics: Why I'm Staying On The Sidelines - Seeking Alpha
- 18 days ago - Relative Strength Alert For Soleno Therapeutics - Nasdaq
- 19 days ago - SLNO Investors: Contact Kirby McInerney LLP About Investigation into Soleno Therapeutics, Inc. - Business Wire
- 19 days ago - Soleno Therapeutics reports prelim Q4 rev above estimate - Seeking Alpha
- 20 days ago - Soleno Therapeutics (SLNO) Achieves Milestone with VYKAT XR Launch - GuruFocus
- 22 days ago - SLNO Investigation: Investors Encouraged to Contact Kirby McInerney LLP - GlobeNewsWire
- 24 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO - PRNewsWire